Nanomedicine: a hope for mankind

Abstract

Quality. Current statistics unfold that due to the poor quality of the present system, 15 % of the patient admitted to the hospitals suffered from the adverse event.10-20 % of all adverse events are caused by a medication error. The outcome of the conventional health care R&D labs is lesser than the cost invested. Usually, the patient responds to the therapy is always lower than 50 % in most chronic disease such as; Migraine, Rheumatoid arthritis, Osteoporosis, Alzheimer, Oncology, etc.2 Moreover, the present diagnostic system is based on the symptoms rather than prediction / prevention and lacking in early diagnosis/managing illness. To overcome these issues, development of the new technology is crucial. Hence, nanomedicine made the revolution in the healthcare by greatly improved directed therapies for treating cancer and cardiovascular disease using new nano-drug / gene delivery systems. The tiny implantable devices help to supervise the health precisely and nano-biosensor provides the data at the earliest stage of the disease.